Adaptiiv, HP, Varian Partner to Further Personalize Radiation Oncology

Adaptiiv is partnering with HP and Varian (a Siemens Healthineers company) to advance quality of and access to personalized cancer care for U.S. patients via 3D-printed medical devices.
 
HP’s Multi Jet Fusion can be used to produce high-quality, flexible, patient-specific parts at high throughput. It’s suitable for healthcare use due to speed, quality, and economic advantages through scalable manufacturing processes.
 
“The combined technology scale of HP and Varian, along with the leading-edge personalization workflow of Adaptiiv, provides the improved solution that clinicians and patients deserve,” Louis Kim, Vice President, 3D Printing at HP told the press. “HP is proud to be a part of this collaboration to help advance the treatment of cancers worldwide.”
 
Adaptiiv will also work with Vairan to expand access to the patient-specific devices.
 
“We are energized by Adaptiiv’s innovation and this opportunity with HP to further expand our cancer care ecosystem. Addressing our customers’ needs is our top priority, and we are confident that this commercial commitment will help us do just that by advancing interoperability with Adaptiiv’s 3D printed medical devices for external beam radiation therapy,” said Ben Moga, Director, Strategic Alliances and Synergy Investments at Varian.
 
Adaptiiv earned U.S. Food and Drug Administration (FDA) clearance earlier this year for its On Demand service to manufacture and deliver 3D-printed patient-specific medical devices. These conform to the patient’s anatomy to improve accuracy of dose delivery. Integrating Adaptiiv software can also help reduce patient setup time in CT simulation and on the treatment unit.